| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |